Sunday 11 October 2026
Export all SNY data to Excel Powerpack
Sanofi
SNY Healthcare Drug Manufacturers General
Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS fell 90.8%, free cash flow fell 45.1% and total debt rose 8.23%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
40.07
0.16
−0.40%
Follow SNY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | — | 7 | — |
+8 more TTM periods Free account |
| 5.87% | 0.00% | 10.94% | 0.00% | ||
| 3.21% | 6.06% | 6.16% | 7.01% | ||
ROIC |
6.58% | 6.12% | 6.57% | 6.17% | |
Return on Tangible Assets |
40.46% | 72.55% | 61.72% | 75.08% | |
Average Days of Receivables |
68.60 | 3.75 | 68.81 | 4.53 | |
Free Cash Flow per Share |
6.08 | 0.00 | 7.62 | 0.00 | |
Free Cash Flow |
14,542.46 | — | 18,607.12 | — | |
Capital Expenditures |
(7,054.14) | — | (7,417.62) | — | |
| Other line items | |||||
Cash ROIC |
12.82% | 0.00% | 16.79% | 0.00% | |
Accounts Receivable Turnover |
5.69 | 105.97 | 5.55 | 9.30 | |
Accounts Payable Turnover |
1.90 | 0.62 | 1.79 | 0.76 | |
Inventory Turnover |
1.30 | 0.61 | 1.36 | 0.64 | |
Average Days of Payables |
195.73 | 630.21 | 205.90 | 732.11 | |
Days of Inventory on Hand |
304.59 | 652.28 | 285.70 | 815.34 | |
Tax Rate |
(0.22) | (0.17) | (0.17) | (0.18) | |
Research and Development Expense of Revenue |
16.58% | 16.43% | 16.79% | 18.12% | |
Selling, General and Administrative Expense of Revenue |
20.11% | 20.39% | 20.43% | 19.05% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
13.21 | 15.83 | 15.43 | 10.91 | |
Operating CF/Net income |
4.61 | 0.00 | 2.94 | 0.00 | |
Depreciation/Fixed assets |
1.30 | 0.00 | 1.22 | 0.00 | |
Capex/Depreciation |
(0.45) | — | (0.53) | — | |
Revenue per Share |
23.80 | 22.77 | 21.65 | 19.20 | |
Operating CF per Share |
9.02 | 0.00 | 10.66 | 0.00 | |
Capex per Share |
(2.95) | 0.00 | (3.04) | 0.00 | |
Capex to Sales |
0.12 | 0.00 | 0.14 | 0.00 |
Columns are period end dates